by McKesson Ventures | Apr 21, 2026 | Media Coverage
Michelle Snyder, McKesson Ventures’ Partner and host of the Breaking Health podcast, recently spoke with Atropos Health CEO and co-founder Brigham Hyde, PhD on an episode of the show. Snyder interviewed Hyde about impressive movements that companies have been making...
by McKesson Ventures | Feb 3, 2026 | Press Releases
Premier midlife women’s healthcare company Midi Health announced that it has officially surpassed a $1 billion valuation—the first company in its field to achieve this incredible milestone. The company’s latest funding round included a number of new investors,...
by McKesson Ventures | Jan 27, 2026 | Press Releases
AI-based surgical care innovator Oath Surgical has announced that it will be partnering with NVIDIA to increase support for the OathOS clinical intelligence platform through the use of NVIDIA’s advanced spatial AI infrastructure. This will supply surgeons in Oath’s...
by McKesson Ventures | Jan 12, 2026 | Press Releases
Real-world clinical data provider Atropos Health has announced that it will be making its Commercial Analytics solutions available to life science leaders. This new offering will harness the speed, accuracy, and efficiency of the company’s AI-powered ChatRWD®...
by McKesson Ventures | Jan 7, 2026 | Press Releases
Biotechnology research and life sciences dealmaking company Prudentia Sciences recently announced that it has secured $20 million in Series A financing, led by McKesson Ventures with participation from SignalFire. This newest investment brings Prudentia’s total...
